These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30818795)

  • 1. Will Attention by Vaccine Developers to the Host's Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?
    Sealy RE; Jones BG; Surman SL; Penkert RR; Pelletier S; Neale G; Hurwitz JL
    Vaccines (Basel); 2019 Feb; 7(1):. PubMed ID: 30818795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of estrogen receptors to switch sites and regulatory elements in the immunoglobulin heavy chain locus of activated B cells suggests a direct influence of estrogen on antibody expression.
    Jones BG; Penkert RR; Xu B; Fan Y; Neale G; Gearhart PJ; Hurwitz JL
    Mol Immunol; 2016 Sep; 77():97-102. PubMed ID: 27494228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hotspots for Vitamin-Steroid-Thyroid Hormone Response Elements Within Switch Regions of Immunoglobulin Heavy Chain Loci Predict a Direct Influence of Vitamins and Hormones on B Cell Class Switch Recombination.
    Hurwitz JL; Penkert RR; Xu B; Fan Y; Partridge JF; Maul RW; Gearhart PJ
    Viral Immunol; 2016 Mar; 29(2):132-6. PubMed ID: 26741514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.
    van Diepen A; Brand HK; de Waal L; Bijl M; Jong VL; Kuiken T; van Amerongen G; van den Ham HJ; Eijkemans MJ; Osterhaus AD; Hermans PW; Andeweg AC
    J Virol; 2015 May; 89(9):5022-31. PubMed ID: 25694607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parainfluenza Virus 5 Expressing Wild-Type or Prefusion Respiratory Syncytial Virus (RSV) Fusion Protein Protects Mice and Cotton Rats from RSV Challenge.
    Phan SI; Zengel JR; Wei H; Li Z; Wang D; He B
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for control of fertility and hormone dependent cancers.
    Talwar GP; Singh O; Pal R; Chatterjee N
    Int J Immunopharmacol; 1992 Apr; 14(3):511-4. PubMed ID: 1618603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease.
    Wiegand MA; Gori-Savellini G; Gandolfo C; Papa G; Kaufmann C; Felder E; Ginori A; Disanto MG; Spina D; Cusi MG
    J Virol; 2017 May; 91(10):. PubMed ID: 28250126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraception.
    Jones WR
    Baillieres Clin Obstet Gynaecol; 1992 Sep; 6(3):629-40. PubMed ID: 1446424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination.
    Patel N; Penkert RR; Jones BG; Sealy RE; Surman SL; Sun Y; Tang L; DeBeauchamp J; Webb A; Richardson J; Heine R; Dallas RH; Ross AC; Webby R; Hurwitz JL
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31575021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination for contraception.
    Jones WR
    Aust N Z J Obstet Gynaecol; 1994 Jun; 34(3):320-9. PubMed ID: 7848209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in RSV vaccine research and development - A global agenda.
    Higgins D; Trujillo C; Keech C
    Vaccine; 2016 Jun; 34(26):2870-2875. PubMed ID: 27105562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop.
    Roberts JN; Graham BS; Karron RA; Munoz FM; Falsey AR; Anderson LJ; Marshall V; Kim S; Beeler JA
    Vaccine; 2016 Sep; 34(41):4843-4849. PubMed ID: 27566900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine pattern is solely influenced by priming vaccine but immunity and disease by both priming and boosting vaccines in mice challenged with respiratory syncytial virus.
    Tang YW
    Virus Res; 2004 Jan; 99(1):81-7. PubMed ID: 14687950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of respiratory syncytial virus vaccine development.
    Polack FP; Karron RA
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S65-73. PubMed ID: 14730272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines against human respiratory syncytial virus in clinical trials, where are we now?
    Rossey I; Saelens X
    Expert Rev Vaccines; 2019 Oct; 18(10):1053-1067. PubMed ID: 31587585
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.